Stop the progression of multiple sclerosis (ALS) may be possible through a treatment called “copper-ATSM”, according to the results of a study published in the medical journal Neurobiology of Disease. Conclusions obtained on mice.
Researchers at Oregon State University (USA) administered copper-ATSM to genetically modified mice. Guinea pigs that should have lived 2 weeks survived an additional 650 days. The researchers also analyzed that if they interrupted the treatment, they observed the disappearance and then the reappearance of symptoms of the ALS within two months of stopping treatment. On the other hand, as soon as they re-administered copper-ATSM, the mice grew in size and survival without progression of the disease could be prolonged from 6 to 12 months.
lower-abdomen-retailed
Encouraging results to test on humans through clinical trials, because there is no treatment for this pathology. AT”An approach, specify the experts, much more complex than simple copper supplementation, which can be toxic in even moderate doses says Joseph Beckman, a professor of biochemistry and biophysics at Oregon State University’s college of sciences.
Multiple sclerosis in numbers
The multiple sclerosis is an autoimmune disease that affects between 70,000 and 90,000 people in France. Each year, between 3000 and 5000 new cases are diagnosed, with a clear predominance among women. Difficulty walking, tired, weakness in the limbs, chronic pain are among the symptoms of the disease. There is no treatment to cure MS, but several studies have shown that diet would have a role to play in reducing the symptoms of the disease or even curbing it. Coffee and vitamin D would limit the severity of the disease and could prevent its onset. On the other hand, salt and red wine should be banned from the plates of people affected by this disease.
Read also:
Multiple sclerosis: coffee and vitamin D would reduce the risk
Multiple sclerosis: physical exercise on a game console improves the health of patients
Multiple sclerosis: vitamin D deficiency doubles the risk